tiprankstipranks
Eupraxia Pharmaceuticals (TSE:EPRX)
TSX:EPRX

Eupraxia Pharmaceuticals (EPRX) Stock Forecast & Price Target

13 Followers
See the Price Targets and Ratings of:

EPRX Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Eupraxia
Pharmaceuticals
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

EPRX Stock 12 Month Forecast

There Are No Analyst Ratings for TSE:EPRX In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

EPRX Financial Forecast

EPRX Earnings Forecast

Next quarter’s earnings estimate for EPRX is -C$0.23 with a range of -C$0.23 to -C$0.23. The previous quarter’s EPS was ―. EPRX beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 38.22% of the time in the same period. In the last calendar year EPRX has Underperformed its overall industry.
Next quarter’s earnings estimate for EPRX is -C$0.23 with a range of -C$0.23 to -C$0.23. The previous quarter’s EPS was ―. EPRX beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 38.22% of the time in the same period. In the last calendar year EPRX has Underperformed its overall industry.
No data currently available

EPRX Sales Forecast

Next quarter’s sales forecast for EPRX is C$0.00 with a range of C$0.00 to C$0.00. The previous quarter’s sales results were ―. EPRX beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 53.36% of the time in the same period. In the last calendar year EPRX has Underperformed its overall industry.
Next quarter’s sales forecast for EPRX is C$0.00 with a range of C$0.00 to C$0.00. The previous quarter’s sales results were ―. EPRX beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 53.36% of the time in the same period. In the last calendar year EPRX has Underperformed its overall industry.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Raymond James
C$19C$16.5
Buy
371.43%
Upside
Reiterated
03/18/24
Eupraxia Pharmaceuticals (EPRX:CN) PT Lowered to Cdn$16.50 at Raymond JamesRaymond James analyst Rahul Sarugaser lowered the price target on Eupraxia Pharmaceuticals (EPRX:CN) to Cdn$16.50 (from Cdn$19.00) while maintaining a Strong Buy rating.

Best Analysts Covering Eupraxia Pharmaceuticals

Which Analyst Should I Follow If I Want to Buy TSE:EPRX and Sell After:
1 Month
Rahul SarugaserRaymond James
Success Rate
1/4 ratings generated profit
25%
Average Return
-9.65%
reiterated a buy rating 4 months ago
Copying Rahul Sarugaser's trades and holding each position for 1 Month would result in 25.00% of your transactions generating a profit, with an average return of -9.65% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
3 Months
Rahul SarugaserRaymond James
Success Rate
0/4 ratings generated profit
0%
Average Return
-22.32%
reiterated a buy rating 4 months ago
Copying Rahul Sarugaser's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -22.32% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
1 Year
Rahul SarugaserRaymond James
Success Rate
0/4 ratings generated profit
0%
Average Return
-43.18%
reiterated a buy rating 4 months ago
Copying Rahul Sarugaser's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -43.18% per trade.
2 Years
Rahul SarugaserRaymond James
Success Rate
0/4 ratings generated profit
0%
Average Return
-43.30%
reiterated a buy rating 4 months ago
Copying Rahul Sarugaser's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -43.30% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

EPRX Analyst Recommendation Trends

Rating
Apr 22
Jun 23
Sep 23
Feb 24
Mar 24
Strong Buy
3
4
4
4
3
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
4
4
4
3
In the current month, EPRX has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. EPRX average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

EPRX Stock Forecast FAQ

What is TSE:EPRX’s average 12-month price target, according to analysts?
Currently, no data Available
What is TSE:EPRX’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for TSE:EPRX, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is TSE:EPRX a Buy, Sell or Hold?
      Currently, no data Available
      What is Eupraxia Pharmaceuticals’s price target?
      Currently, no data Available
      What do analysts say about Eupraxia Pharmaceuticals?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of TSE:EPRX?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis